Skip to Content
Merck
All Photos(1)

Documents

AB2080

Sigma-Aldrich

Anti-CD44v6 Antibody, exon v6

Chemicon®, from rabbit

Synonym(s):

Anti-CDW44, Anti-ECMR-III, Anti-HCELL, Anti-HUTCH-I, Anti-IN, Anti-LHR, Anti-MC56, Anti-MDU2, Anti-MDU3, Anti-MIC4, Anti-Pgp1

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41

biological source

rabbit

Quality Level

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

polyclonal

species reactivity

human, canine, mouse, bovine, pig, rabbit

manufacturer/tradename

Chemicon®

technique(s)

ELISA: suitable
flow cytometry: suitable
immunocytochemistry: suitable
immunohistochemistry: suitable (paraffin)
immunoprecipitation (IP): suitable
western blot: suitable

UniProt accession no.

shipped in

wet ice

target post-translational modification

unmodified

Gene Information

human ... CD44(960)

Related Categories

Specificity

CD44v6 (Approximant 200-250 kDa)

Immunogen

Epitope: exon v6
Synthetic peptide of human CD44v6

Application

Anti-CD44v6 Antibody, exon v6 is an antibody against CD44v6 for use in ELISA, FC, IP, WB, IC, IH(P).
ELISA: 1:1000-1:2000

Flow Cytometry: 1:500-1:1000

Immunofluorescence: 1:100-1:200

Immunohistostaining of paraffin embedded tissue: 1:150-1:250

Immunoprecipitation: 1:100-1:200

Western Blotting 1:5000-1:10,000

RIA: 1:5,000

Optimal working dilutions must be determined by the end user.
Research Category
Cell Structure
Research Sub Category
Adhesion (CAMs)

Linkage

Replaces: 04-1123

Physical form

Format: Purified
Purified IgG. Liquid in 10 mM sodium phosphate (pH 7.5) with 150 mM NaCl and 0.01% sodium azide.

Storage and Stability

Maintain at 2-8°C in undiluted aliquots for up to 12 months from date of receipt.

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class Code

10 - Combustible liquids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Sureerat Padthaisong et al.
Journal of translational medicine, 18(1), 64-64 (2020-02-11)
Cancer recurrence is the important problem of cholangiocarcinoma (CCA) patients, lead to a very high mortality rate. Therefore, the identification of candidate markers to predict CCA recurrence is needed in order to effectively manage the disease. This study aims to
Yulian Wang et al.
Advanced science (Weinheim, Baden-Wurttemberg, Germany), 8(13), 2004929-2004929 (2021-07-15)
The blood-brain barrier (BBB) is the most restrictive and complicated barrier that keeps most biomolecules and drugs from the brain. An efficient brain delivery strategy is urgently needed for the treatment of brain diseases. Based on the studies of brain-targeting
Expression and localization of membrane-type-1 matrix metalloproteinase, CD 44, and laminin-5gamma2 chain during colorectal carcinoma tumor progression.
Murai, S; Umemiya, T; Seiki, M; Harigaya, K
Virchows Archiv null
Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium.
Dall, P; Heider, KH; Hekele, A; von Minckwitz, G; Kaufmann, M; Ponta, H; Herrlich, P
Cancer Research null
Ayse Sahaboglu et al.
Scientific reports, 6, 39537-39537 (2016-12-23)
The enzyme poly-ADP-ribose-polymerase (PARP) mediates DNA-repair and rearrangements of the nuclear chromatin. Generally, PARP activity is thought to promote cell survival and in recent years a number of PARP inhibitors have been clinically developed for cancer treatment. Paradoxically, PARP activity

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service